Cargando…
Economic burden of antimicrobial resistance and inappropriate empiric treatment in Thailand
OBJECTIVE: To quantify the economic burden of bacterial antimicrobial resistance in Thailand and estimate potential savings from improving the rate of appropriate empiric treatment, where effective coverage is provided within the first days of infection. DESIGN: Cost-of-illness study. METHODS: A cos...
Autores principales: | Kongnakorn, Thitima, Tichy, Eszter, Kengkla, Kirati, Kanokwanvimol, Nuttawan, Suthipinijtham, Pichaya, Phuripakathorn, Chanyapat, Al Taie, Amer |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cambridge University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10369446/ https://www.ncbi.nlm.nih.gov/pubmed/37502249 http://dx.doi.org/10.1017/ash.2023.169 |
Ejemplares similares
-
Cost-effectiveness analysis comparing ceftazidime/avibactam (CAZ-AVI) as empirical treatment comparing to ceftolozane/tazobactam and to meropenem for complicated intra-abdominal infection (cIAI)
por: Kongnakorn, Thitima, et al.
Publicado: (2019) -
Economic Burden Of Inappropriate Empiric Antibiotic Therapy: A Report From Southern Iran
por: Sadatsharifi, Arman, et al.
Publicado: (2019) -
Cost-utility and budget impact analyses of cervical cancer screening using self-collected samples for HPV DNA testing in Thailand
por: Kositamongkol, Chayanis, et al.
Publicado: (2023) -
Effect of drug use calendar on adherence to iron chelation therapy in young thalassemia patients
por: Chawsamtong, Sriwatree, et al.
Publicado: (2022) -
Economic implications of using bendamustine, alemtuzumab, or chlorambucil as a first-line therapy for chronic lymphocytic leukemia in the US: a cost-effectiveness analysis
por: Kongnakorn, Thitima, et al.
Publicado: (2014)